Bcl10 Is Involved in t(1;14)(p22;q32) of MALT B Cell Lymphoma and Mutated in Multiple Tumor Types

[1]  Sharad Kumar,et al.  Prodomain-dependent Nuclear Localization of the Caspase-2 (Nedd2) Precursor , 1998, The Journal of Biological Chemistry.

[2]  Gerhard Wagner,et al.  Solution Structure of the RAIDD CARD and Model for CARD/CARD Interaction in Caspase-2 and Caspase-9 Recruitment , 1998, Cell.

[3]  L. Peso,et al.  Erratum: RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates cd95-mediated apoptosis (Journal of Biological Chemistry (1998) 273 (12296-12300)) , 1998 .

[4]  F. Martinon,et al.  Identification of CARDIAK, a RIP-like kinase that associates with caspase-1 , 1998, Current Biology.

[5]  E. Jaffe,et al.  Epstein-Barr Virus in Nasal Lymphomas Contains Multiple Ongoing Mutations in the EBNA-1 Gene , 1998 .

[6]  V. Dixit,et al.  RIP2 Is a Novel NF-κB-activating and Cell Death-inducing Kinase* , 1998, The Journal of Biological Chemistry.

[7]  U. Storb,et al.  Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. , 1998, Science.

[8]  L. del Peso,et al.  RICK, a Novel Protein Kinase Containing a Caspase Recruitment Domain, Interacts with CLARP and Regulates CD95-mediated Apoptosis* , 1998, The Journal of Biological Chemistry.

[9]  S. Chen,et al.  ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[10]  K. Aldape,et al.  An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[11]  D. Cortez,et al.  A requirement for NF-κB activation in Bcr–Abl-mediated transformation , 1998 .

[12]  M. Dyer,et al.  Molecular cloning of translocation t(1;14)(q21;q32) defines a novel gene (BCL9) at chromosome 1q21. , 1998, Blood.

[13]  Seamus J. Martin,et al.  Inhibition of TNF-induced apoptosis by NF-κB , 1998 .

[14]  V. Dixit,et al.  RIP2 is a novel NF-kappaB-activating and cell death-inducing kinase. , 1998, The Journal of biological chemistry.

[15]  M. Raffeld,et al.  Epstein-Barr virus in nasal lymphomas contains multiple ongoing mutations in the EBNA-1 gene. , 1998, Blood.

[16]  C. Y. Wang,et al.  Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras. , 1997, Science.

[17]  B Johansson,et al.  Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. , 1997, Cancer research.

[18]  P. Bucher,et al.  The CARD domain: a new apoptotic signalling motif. , 1997, Trends in biochemical sciences.

[19]  P. Isaacson,et al.  Genetic evidence for a clonal link between low and high‐grade components in gastric MALT B‐cell lymphoma , 1997, Histopathology.

[20]  L. Peterson,et al.  Recurring structural chromosome abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides/Sézary syndrome. , 1997, Blood.

[21]  P. Isaacson,et al.  Immersion-histo polymerase chain reaction: a practical tool for visualization of single-copy genes in tissue sections. , 1997, The American journal of pathology.

[22]  S. Korsmeyer,et al.  Bax suppresses tumorigenesis and stimulates apoptosis in vivo , 1997, Nature.

[23]  Vishva M. Dixit,et al.  RAIDD is a new 'death' adaptor molecule , 1997, Nature.

[24]  M. Dyer,et al.  Rapid molecular cloning of rearrangements of the IGHJ locus using long-distance inverse polymerase chain reaction. , 1997, Blood.

[25]  T. Crook,et al.  Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7. , 1996, Oncogene.

[26]  R. Warnke,et al.  Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated Bcl-2 gene. , 1996, Blood.

[27]  S. Jhanwar,et al.  Loss of heterozygosity analysis defines a critical region in chromosome 1p22 commonly deleted in human malignant mesothelioma. , 1996, Cancer research.

[28]  D. Katz,et al.  Inhibition of NF‐kappaB/Rel induces apoptosis of murine B cells. , 1996, The EMBO journal.

[29]  E. Schuuring,et al.  Direct visualization of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by multicolor DNA fiber fluorescence in situ hybridization. , 1996, Blood.

[30]  K. Offit,et al.  Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B-cell lymphoma. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[31]  K. Offit,et al.  BCL-6 protein is expressed in germinal-center B cells. , 1995, Blood.

[32]  E. Telford,et al.  The DNA sequence of equine herpesvirus 2. , 1995, Journal of molecular biology.

[33]  P. Isaacson,et al.  The biology of low grade MALT lymphoma. , 1995, Journal of clinical pathology.

[34]  K. Vousden,et al.  Transcriptional activation by p53 correlates with suppression of growth but not transformation , 1994, Cell.

[35]  R. Chaganti,et al.  Loss of heterozygosity identifies multiple sites of allelic deletions on chromosome 1 in human male germ cell tumors. , 1994, Cancer research.

[36]  Annick,et al.  Prognostic value of chromosomal abnormalities in follicular lymphoma. , 1994, Blood.

[37]  D. Eick,et al.  Ongoing mutations in the N-terminal domain of c-Myc affect transactivation in Burkitt's lymphoma cell lines. , 1994, Oncogene.

[38]  T. C. Diss,et al.  Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori , 1993, The Lancet.

[39]  E. E. Max,et al.  Variable IgH chain enhancer activity in Burkitt's lymphomas suggests an additional, direct mechanism of c-myc deregulation. , 1993, Journal of immunology.

[40]  P. Isaacson,et al.  Proliferation and differentiation of tumour cells from B‐cell lymphoma of mucosa‐associated lymphoid tissue in vitro , 1993, The Journal of pathology.

[41]  P. Isaacson,et al.  Cytogenetic study of B-cell lymphoma of mucosa-associated lymphoid tissue. , 1992, Cancer genetics and cytogenetics.

[42]  S. Korsmeyer,et al.  Immunolocalization of the Bcl-2 protein within hematopoietic neoplasms. , 1991, Blood.

[43]  I. Magrath.  The pathogenesis of Burkitt's lymphoma. , 1990, Advances in cancer research.

[44]  M. Oren,et al.  Wild-type p53 can inhibit oncogene-mediated focus formation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[45]  N. Jones,et al.  Mutational analysis of the adenovirus E1a gene: the role of transcriptional regulation in transformation. , 1987, The EMBO journal.

[46]  M. Oren,et al.  Overproduction of p53 antigen makes established cells highly tumorigenic , 1985, Nature.

[47]  P. Nowell,et al.  Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. , 1984, Science.

[48]  T. Rabbitts,et al.  Altered nucleotide sequences of a translocated c-myc gene in Burkitt lymphoma , 1983, Nature.

[49]  R. Weinberg,et al.  Isolation of a transforming sequence from a human bladder carcinoma cell line , 1982, Cell.